EVIDENT and Ultivue: Collaboration provides a convenient, fast tool for multiplexed immunofluorescence imaging in translational studies. WALTHAM and CAMBRIDGE, Mass., (Nov. 7, 2022)—Evident Corporatio...
Carl Zeiss Microscopy, LLC, has announced that it has entered into an agreement with Ultivue Inc. to co-market Ultivue’s multiplex biomarker assays for tissue phenotyping with the ZEISS Axioscan whole...
CAMBRIDGE, Mass. & BERN, Switzerland–(BUSINESS WIRE)–Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies and, the Translational R...
Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige, the global leader in AI-based diagnostic software in pathology, today announced a partnership to collaborate...
Community Engagement:
Exclusive Content Access:
Contribution Opportunities:
Career Advancement:
Need assistance with registration? Contact our support team at admin@pathologynews.com
Your Next Career Move In Digital Pathology Awaits!
Community Engagement:
Exclusive Content Access:
Contribution Opportunities:
Career Advancement:
Need assistance with registration? Contact our support team at admin@pathologynews.com